๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small-cell lung carcinoma and neuroblastoma

โœ Scribed by K. Patel; S. E. Moore; G. Dickson; R. J. Rossell; P. C. Beverley; J. T. Kemshead; F. S. Walsh


Publisher
John Wiley and Sons
Year
1989
Tongue
French
Weight
967 KB
Volume
44
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

โœฆ Synopsis


We describe reagents from 2 workshops which had been identified as recognizing the same or very similar antigens based on their tissue reactivity. Examination of their tissue specificity led us to the conclusion that this was similar to the expression of the neural cell adhesion molecule (NCAM). We also describe the use of a transfection-based assay to show that these reagents do recognize NCAM. 3T3 cells were transfected with a full-length clone of human NCAM. Indirect immunofluorescence studies showed binding of all related antibodies to the transfectants, but not to the control 3T3 cells. In addition, biochemical analysis using certain antibodies in the cluster confirm that they detect NCAM in the transfectants. Our study shows the benefits of using workshops to compare monoclonal antibodies and a molecular approach to define the antigens recognized by such reagents.


๐Ÿ“œ SIMILAR VOLUMES


Biodistribution of a monoclonal antibody
โœ O. C. Boerman; E. P. Mijnheere; J. L. V. Broers; G. P. Vooijs; F. C. S. Ramaeker ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 795 KB

The purpose of this investigation was to determine the targeting potential of the murine monoclonal antibody (MAb) RNL-I for human small-cell lung cancer (SCLC) in a nude mouse model. RNL-I is preferentially reactive with SCLC and lung carcinoids, and was classified as a cluster-I MAb as defined by